Experience

Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $500 million aggregate…

Davis Polk is advising A.P. Moller – Maersk A/S in connection with its $7.45 billion disposal of Maersk Oil to Total S.A. Under the agreed terms, Maersk will receive $4.95…

Davis Polk advised the joint book-running managers in connection with the initial public offering of 40,250,000 units of Capitol Investment Corp. IV, including 5,250,000 units…

Davis Polk is advising Verisk Analytics, Inc. in connection with its £250 million acquisition of Sequel from HgCapital and other Sequel shareholders. The transaction is expected to close in…

Davis Polk advised the underwriters in a registered shelf takedown of 6,612,500 American Depositary Shares by YY Inc. The total proceeds of the shelf takedown were approximately $442…

Davis Polk advised Murphy Oil Corporation on an SEC-registered offering of $550 million aggregate principal amount of its 5.750% notes due 2025. The net proceeds of the offering are…

Davis Polk advised the underwriter in connection with a block trade of 10,000,000 common shares of Genpact Limited by funds affiliated with Bain Capital Investors, LLC and its co…

Davis Polk advised the underwriter in connection with the $39.3 million SEC-registered offering of 2,500,000 ordinary shares of Oxford Immunotec Global PLC. The ordinary shares are…

Davis Polk advised the joint lead managers in connection with the Regulation S offering of $200 million 7.00% notes due 2020 by 21Vianet Group, Inc.21Vianet Group, Inc. is a carrier…

Davis Polk advised DXC Technology Company on its SEC-registered offering of $650 million aggregate principal amount of senior floating-rate notes due 2021.  DXC is an end-to-end IT…